These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention on their clinical significance? Katholi RE; Rocha-Singh KJ Prog Cardiovasc Dis; 2009; 52(3):243-8. PubMed ID: 19917336 [TBL] [Abstract][Full Text] [Related]
29. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL; J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423 [TBL] [Abstract][Full Text] [Related]
30. [Renal denervation a new treatment option in resistant arterial hypertension]. Himmel F; Bode F; Schunkert H; Weil J Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911 [TBL] [Abstract][Full Text] [Related]
31. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence. Hiremath S; Froeschl M; Ruzicka M Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619 [TBL] [Abstract][Full Text] [Related]
32. Renal Denervation. Hameed MA; Dasgupta I Adv Exp Med Biol; 2017; 956():261-277. PubMed ID: 27815927 [TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance guided renal denervation using active tracking: first in vivo experience in Swine. Bönner F; Haberkorn S; Behm P; Schnackenburg B; Krüger S; Weiss S; Meyer C; Kelm M; Neizel-Wittke M Int J Cardiovasc Imaging; 2018 Mar; 34(3):431-439. PubMed ID: 28956200 [TBL] [Abstract][Full Text] [Related]
34. Chemical denervation of the renal artery with vincristine for the treatment of resistant arterial hypertension: first-in-man application. Stefanadis C; Toutouzas K; Vlachopoulos C; Tsioufis C; Synetos A; Pietri P; Tousoulis D; Tsiamis E Hellenic J Cardiol; 2013; 54(4):318-21. PubMed ID: 23912924 [TBL] [Abstract][Full Text] [Related]
35. An update on renal artery denervation and its clinical impact on hypertensive disease. Bhat A; Kuang YM; Gan GC; Burgess D; Denniss AR Biomed Res Int; 2015; 2015():607079. PubMed ID: 26495305 [TBL] [Abstract][Full Text] [Related]
36. Next generation renal denervation: chemical "perivascular" renal denervation with alcohol using a novel drug infusion catheter. Fischell TA; Fischell DR; Ghazarossian VE; Vega F; Ebner A Cardiovasc Revasc Med; 2015 Jun; 16(4):221-7. PubMed ID: 25979565 [TBL] [Abstract][Full Text] [Related]
37. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect. Václavík J; Táborský M; Richter D Clin Exp Hypertens; 2013; 35(3):192-4. PubMed ID: 22891761 [TBL] [Abstract][Full Text] [Related]
39. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension. van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672 [TBL] [Abstract][Full Text] [Related]
40. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease. Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]